LYZ and Crohn disease: LRRK2 has previously been implicated in Crohn’s disease through its expression in intestinal epithelial cells, specifically in Paneth cells, where it was shown to be required for anti-microbial peptide lysozyme secretion (Zhang et al, 2015).